Amoxicillin dosing recommendations are very different in European countries: a cross-sectional survey

Clinical Microbiology and Infection

Volumn 23, Issue 6, 2017, Pages 414-415

  Pulcini, C ^a   Beovic, B ^a   Cavalie P ^a   Deptula, A ^a   Dyar, O ^a   Gyssens, I ^a   Kern, W ^a   Knepper, V ^a   Kofteridis, D ^a   Hanberger, H ^a   Huttner, B ^a   Messiaen, P ^a   Pagani, L ^a   Pano Pardo, J ^a   Rodriguez Bano, J ^a   Skov Simonsen, G ^a   Vlahovic Palcevski V ^a   Zarb, P ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT;

BACTEREMIA; CELLULITIS; CROATIA; CROSS-SECTIONAL STUDY; CYSTITIS; DRUG INDICATION; ENGLAND; ENTEROCOCCAL INFECTION; EUROPEAN; FRANCE; GERMANY; GREECE; HEALTH SURVEY; HUMAN; ITALY; LETTER; MAXILLA SINUSITIS; NETHERLANDS; NORWAY; OTITIS MEDIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SPAIN; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS PNEUMONIA; ADULT; BACTERIAL INFECTION; COMPARATIVE STUDY; DRUG UTILIZATION; EUROPE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; EUROPE; FEMALE; HUMANS; MALE;

EID: 85008220499     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.11.013     Document Type: Letter

References (5)

1. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2016. Available at: http://www.whocc.no/atc_ddd_index/. [Accessed 15 December 2016].
2. ECDC. ESAC-Net Report. Surveillance of antimicrobial consumption in Europe 2012. Available at: http://ecdc.europa.eu/en/healthtopics/antimicrobial-resistance-and-consumption/antimicrobial-consumption/publications-documents/Pages/publications.aspx. [Accessed 15 December 2016].
3. Bruyndonckx, R., Hens, N., Aerts, M., Goossens, H., Molenberghs, G., Coenen, S., Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages. J Antimicrob Chemother 69 (2014), 1981–1986.
4. Davey, P., Ferech, M., Ansari, F., Muller, A., Goossens, H., Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother 62 (2008), 1441–1447.
5. DRIVE-AB. WP1a: Responsible use of antibiotics, new and old. Available at: http://drive-ab.eu/workstreams-view/wp1a-responsible-use-of-antibiotics-both-new-and-old/. [Accessed: 15 December 2016].